Search Form
First, enter a politician or zip code
Now, choose a category

Key Votes

HB 631 - Prohibits Unwarranted Price Hikes on Generic Drugs - Maryland Key Vote

Shane Robinson Co-Sponsored (Introduced) this Legislation.

Read statements Shane Robinson made in this general time period.

Timeline

Issues Related to HB 631

Stage Details

Legislation - Concurrence Vote Passed (House) (137-2) -

Title: Prohibits Unwarranted Price Hikes on Generic Drugs

Legislation - Bill Passed With Amendment (Senate) (38-7) - (Key vote)
See How Your Politicians Voted

Title: Prohibits Unwarranted Price Hikes on Generic Drugs

Vote Result
Yea Votes
Nay Votes
Vote Smart's Synopsis:

Vote to pass a bill that prohibits a wholesale distributor from increasing a price of an essential off-patent or generic drug under certain circumstances.

Highlights:

 

  • Specifies that distributors are still allowed to raise the price of drugs if it is directly attributable to increases in costs for the drug imposed by the manufacturer on the distributor (Sec. 1).

  • Specifies that information provided to the Attorney General under the act is classified as confidential commercial information unless confidentiality is waived by the manufacturer or distributor (Sec. 1).

  • Authorizes the Maryland Medical Assistance Program to notify the Attorney General if the price increase (Sec. 1):

    • Results in a 50% or more increase in wholesale acquisition cost of of the drug;

    • Results in a single dose costing an individual more than $80;

    • Results in a 30 day course of treatment costing more than $80 at the wholesale cost or;

    • Causes the drug to be distributed in quantities that do not correspond to a 30 day supply.

  • Requires the manufacturers of essential off-patent or generic drugs to submit a statement to the Attorney General upon his or her request that itemizes the materials and costs during drug production and identifies the circumstances and timing of the manufacturer’s expansion of access to the drug in question (Sec. 1).

  • Specifies that the Attorney General may require a manufacturer or wholesale distributor to produce any documents or records relevant to a determination of whether a violation of law has occurred (Sec. 1).

  • Establishes a penalty of $10,000 for each violation of this act (Sec. 1).

  • Requires a manufacturer that has engaged in price gouging to make the price-gouged drug available to all participants in any state health plan or state health program for one year at the price prior to the manufacturer’s violation of this act (Sec. 1).  
Legislation - Bill Passed (House) (137-4) -

Title: Prohibits Unwarranted Price Hikes on Generic Drugs

Legislation - Introduced (House) -

Title: Prohibits Unwarranted Price Hikes on Generic Drugs

Co-sponsors

Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Thank You!

You are about to be redirected to a secure checkout page.

Please note:

The total order amount will read $0.01. This is a card processor fee. Please know that a recurring donation of the amount and frequency that you selected will be processed and initiated tomorrow. You may see a one-time charge of $0.01 on your statement.

Continue to secure page »

Back to top